Used as a key intermediate in the synthesis of bioactive molecules, particularly in pharmaceuticals targeting central nervous system disorders. Shows potential in the development of anticonvulsant and sedative agents due to its structural similarity to known GABAergic compounds. Also employed in research for novel anticancer agents, where it acts as a scaffold for kinase inhibitors. Its derivatives are explored for antimicrobial properties, especially against resistant bacterial strains. Commonly utilized in medicinal chemistry for structure-activity relationship (SAR) studies involving quinazoline-based drugs.